TuisTEVA • TLV
add
Teva Pharmaceutical Industries Ltd
Vorige sluiting
ILAÂ 6Â 189,00
Dagwisseling
ILAÂ 6Â 050,00 - ILAÂ 6Â 213,00
Jaarwisseling
ILAÂ 3Â 355,00 - ILAÂ 7Â 323,00
Markkapitalisasie
19,15Â mjd USD
Gemiddelde volume
891,52Â k
P/V-verhouding
-
Dividend-opbrengs
-
PrimĂŞre beurs
TLV
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Inkomste | 4,33Â mjd | 12,52% |
Bedryfskoste | 1,14Â mjd | 5,05% |
Netto inkomste | -437,00Â m | -733,33% |
Netto winsgrens | -10,09 | -663,69% |
Wins per aandeel | 0,69 | 15,00% |
EBITDA | 1,26Â mjd | 20,98% |
Effektiewe belastingkoers | -21,50% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 3,32Â mjd | 47,58% |
Totale bates | 41,76Â mjd | -0,78% |
Totale aanspreeklikheid | 35,37Â mjd | 2,31% |
Totale ekwiteit | 6,38 mjd | — |
Uitstaande aandele | 1,13 mjd | — |
Prys om te bespreek | 11,57 | — |
Opbrengs op bates | 6,04% | — |
Opbrengs op kapitaal | 9,82% | — |
Kontantvloei
Netto kontantverandering
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | -437,00Â m | -733,33% |
Kontant van bedrywe | 693,00Â m | 13Â 760,00% |
Kontant van beleggings | 268,00Â m | 45,65% |
Kontant van finansiering | — | — |
Netto kontantverandering | 1,06Â mjd | 352,62% |
Beskikbare kontantvloei | 1,28Â mjd | 62,91% |
Meer oor
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States.
Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America.
Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 18th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs. Wikipedia
Gestig
13 Feb. 1944
Webwerf
Werknemers
37Â 000